肝细胞癌合并门静脉癌栓联合肝静脉栓塞介入转化缩小病肝体积后行吲哚菁绿辅助腹腔镜右半肝切除1例报告_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

高伟 ¹ , 吴昊钧 ² , 魏波 ³ ,  陈利平 ²

1. ;
2. ;
3. ;

Corresponding author：

陈利平, Email: schxclp@sina.com

Keywords：

门静脉癌栓; 肝静脉栓塞; 转化治疗; 吲哚菁绿; 腹腔镜右半肝切除

DOI：

10.7507/1007-9424.202207018

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 高伟, 吴昊钧, 魏波, 陈利平. 肝细胞癌合并门静脉癌栓联合肝静脉栓塞介入转化缩小病肝体积后行吲哚菁绿辅助腹腔镜右半肝切除1例报告. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2023, 30(2): 221-223. doi: 10.7507/1007-9424.202207018 Copy

1.	Bruix J, Cheng AL, Meinhardt G, et al. Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: analysis of two phase Ⅲ studies. J Hepatol, 2017, 67(5): 999-1008.
2.	Chao Y, Chung YH, Han G, et al. The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: final results of the START trial. Int J Cancer, 2015, 136(6): 1458-1467.
3.	中国医师协会肝癌专业委员会. 肝细胞癌合并门静脉癌栓多学科诊治中国专家共识(2018年版). 临床肝胆病杂志, 2019, 35(4): 737-743.
4.	程树群, 吴孟超, 陈汉, 等. 肝癌门静脉癌栓分型的影像学意义. 中华普通外科杂志, 2004, 19(4): 200-201.
5.	Cheng SQ, Wu MC, Chen H, et al. Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein. Hepatogastroenterology, 2007, 54(74): 499-502.
6.	Chebaro A, Buc E, Durin T, et al. Liver venous deprivation or associating liver partition and portal vein ligation for staged hepatectomy?: a retrospective multicentric study. Ann Surg, 2021, 274(5): 874-880.
7.	刘杰, 张成武, 洪德飞, 等. 腹腔镜前入路右半肝切除术治疗右肝巨大肿瘤. 中华普通外科杂志, 2017, 32(7): 581-584.
8.	关斌颖, 杨国际, 刘天锡. 吲哚菁绿荧光染色技术在腹腔镜精准肝切除术中的应用体会. 腹腔镜外科杂志, 2020, 25(12): 919-924.

1. Bruix J, Cheng AL, Meinhardt G, et al. Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: analysis of two phase Ⅲ studies. J Hepatol, 2017, 67(5): 999-1008.
2. Chao Y, Chung YH, Han G, et al. The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: final results of the START trial. Int J Cancer, 2015, 136(6): 1458-1467.
3. 中国医师协会肝癌专业委员会. 肝细胞癌合并门静脉癌栓多学科诊治中国专家共识(2018年版). 临床肝胆病杂志, 2019, 35(4): 737-743.
4. 程树群, 吴孟超, 陈汉, 等. 肝癌门静脉癌栓分型的影像学意义. 中华普通外科杂志, 2004, 19(4): 200-201.
5. Cheng SQ, Wu MC, Chen H, et al. Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein. Hepatogastroenterology, 2007, 54(74): 499-502.
6. Chebaro A, Buc E, Durin T, et al. Liver venous deprivation or associating liver partition and portal vein ligation for staged hepatectomy?: a retrospective multicentric study. Ann Surg, 2021, 274(5): 874-880.
7. 刘杰, 张成武, 洪德飞, 等. 腹腔镜前入路右半肝切除术治疗右肝巨大肿瘤. 中华普通外科杂志, 2017, 32(7): 581-584.
8. 关斌颖, 杨国际, 刘天锡. 吲哚菁绿荧光染色技术在腹腔镜精准肝切除术中的应用体会. 腹腔镜外科杂志, 2020, 25(12): 919-924.

Previous Article
Application of DynaCT combined with 3D iGuide puncture technique to microwave ablation of lung cancer FANChen, TANG Haohuan, ZHOU Qi, SUN Feihu, DING Wei, SUN Lei, WANG Weitao, XU Ping, WANG Weidong
Next Article
Application of DynaCT combined with 3D iGuide puncture technique to microwave ablation of lung cancer FANChen, TANG Haohuan, ZHOU Qi, SUN Feihu, DING Wei, SUN Lei, WANG Weitao, XU Ping, WANG Weidong

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

肝细胞癌合并门静脉癌栓联合肝静脉栓塞介入转化缩小病肝体积后行吲哚菁绿辅助腹腔镜右半肝切除1例报告

Abstract Full text Figures/Tables Video References Cited by

Journal type citation(3)

Other types of references(2)

Previous Article

Next Article

Format

Content

1.	李承圣，包绮晗，郝晓燕，潘庆忠，王素珍，石福艳. 基于随机森林算法的胰腺癌术后预测模型构建. 吉林大学学报(医学版). 2022(02): 426-435 . Baidu Scholar
2.	郑立平，沈亦钰，胡春东，费发明，陈徐艰，王兢. 胰体尾癌患者的预后影响因素分析. 中华胰腺病杂志. 2022(02): 127-131 . Baidu Scholar
3.	周永婕，王正峰，张泽亮，王海平，徐雯，黄瑶，张磊，周文策. 胰腺癌术后复发的相关危险因素分析. 现代肿瘤医学. 2022(18): 3330-3335 . Baidu Scholar

1.	王兴弘. 胰腺导管腺癌行胰体尾切除术后复发危险因素分析[D]. 昆明医科大学. 2022. Baidu Scholar
2.	周永婕. 胰腺癌预后影响因素的研究及列线图模型的构建[D]. 兰州大学. 2022. Baidu Scholar